Genetic modification of wheat to overexpress TaDWF4, a key enzyme in brassinosteroid biosynthesis, enabling crops to maintain growth and yield when nitrogen, phosphorus, or potassium are limited. This approach alters sugar signaling so plants perceive adequate nutrition even under reduced fertilizer inputs.
This solution leverages genetic modification of wheat to overexpress TaDWF4, the rate-limiting enzyme in brassinosteroid (BR) biosynthesis. Brassinosteroids are plant hormones that regulate growth and development. The modified plants maintain higher carbon assimilation and biomass production even when grown under reduced nitrogen conditions. The underlying mechanism involves altered sugar fluxes that signal to the plant that nutrient levels are adequate, effectively "tricking" the plant into sustaining growth despite lower fertilizer inputs.
The technology addresses a critical challenge in agriculture: maintaining crop yields while reducing dependence on synthetic fertilizers. If validated across multiple nutrients, this approach could significantly reduce input costs for growers and decrease environmental impacts associated with fertilizer runoff and greenhouse gas emissions.
Key features:
How it works:
The modified wheat plants produce elevated levels of brassinosteroids, which keep sugars moving throughout the plant. This continuous sugar flux serves as a signal that nutrients are adequate, preventing the plant from initiating typical stress responses when nitrogen is limited. Laboratory characterization using RNASeq has shown that TaDWF4 overexpression lines do not exhibit significant gene expression changes under nitrogen-limiting conditions, unlike wild-type plants.
This technology is currently at an advanced validation stage. Controlled environment studies have confirmed that TaDWF4 overexpression lines maintain better growth and yields under reduced nitrogen. Field trials in the UK are planned to validate these findings under real agricultural conditions, testing three nitrogen application levels (100, 200, and 300 kg/ha) and measuring flowering time, ear number, biomass, and final yield.
Hydroponic growth chamber experiments are planned to test the same lines under phosphorus and potassium limitations. If initial biomass differences are observed, subsequent trials will evaluate performance in low-fertility soils supplemented with adequate nutrients excluding the target nutrient. The organization holds a license to grow genetically modified crops in the UK, enabling this comprehensive validation pathway toward agricultural deployment.
NIAB is an independent research organization headquartered in Cambridge, with sites across the UK, combining applied crop research with certification, advisory, and contract R&D for industry. Companies engage through co-located labs and glasshouses, a national network of replicated field trials, and a year-round demonstration farm for evaluation and private pilots. Service units provide seed and variety testing, quality assurance, and bespoke studies, while an industry-facing incubator and flexible pilot plots help move concepts to pre-commercial validation. Research is supported by competitive UK funding, including UKRI programs, alongside contract work, and a business development and IP team manages agreements, licensing, and trial confidentiality.